SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ICO THERAPEUTICS INC
(NQPK:ICOTF Last Sale: .4337 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (ICOTF : $.4337)
$23 million Market Cap at September 12, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today
Vancouver, BC, Research Report Earnings Snapshot - Last 11/28/18
Canada Annual Reports


Is a "Search and Development" company. By focusing efforts on development instead of research, iCo's business model aims to acquire the rights to drugs that are either off-patent, currently approved or near commercialization and develop them by redosing or reformulating them for new or expanded labels. Subsequent development of these therapeutics may include drug delivery technologies-such as sustained release or biodegradable matrices to extend patent coverage.
Historical Charts    Technical Analysis
No Historical Data available for ICOTF

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ICOTF $.4337 $ 0 $.4337 $.4385 11,250 $.272 $.867 54,077
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $23,453

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex